Recruiting
Phase 2

Prospect Eval of Efficacy of CMV-TCIP Direct Letermovir Prophylax After Allogen Hemato Cell Transpla

Sponsor:

UCLA

Code:

NCT06453460

Conditions

CMV

Allogeneic Stem Cell Transplantation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Letermovir

CMV T Cell Immunity Panel (CMV-TCIP)

CMV DNA PCR

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information